BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16611586)

  • 1. The involvement of lipid rafts in Alzheimer's disease.
    Cordy JM; Hooper NM; Turner AJ
    Mol Membr Biol; 2006; 23(1):111-22. PubMed ID: 16611586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein.
    Cordy JM; Hussain I; Dingwall C; Hooper NM; Turner AJ
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11735-40. PubMed ID: 14504402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-secretase processing of the Alzheimer's amyloid protein precursor (APP).
    Marlow L; Cain M; Pappolla MA; Sambamurti K
    J Mol Neurosci; 2003; 20(3):233-9. PubMed ID: 14501002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane rafts in Alzheimer's disease beta-amyloid production.
    Vetrivel KS; Thinakaran G
    Biochim Biophys Acta; 2010 Aug; 1801(8):860-7. PubMed ID: 20303415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lipid boundary separates APP and secretases and limits amyloid beta-peptide generation.
    Kaether C; Haass C
    J Cell Biol; 2004 Dec; 167(5):809-12. PubMed ID: 15583026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase.
    Nunan J; Shearman MS; Checler F; Cappai R; Evin G; Beyreuther K; Masters CL; Small DH
    Eur J Biochem; 2001 Oct; 268(20):5329-36. PubMed ID: 11606195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid rafts play an important role in A beta biogenesis by regulating the beta-secretase pathway.
    Tun H; Marlow L; Pinnix I; Kinsey R; Sambamurti K
    J Mol Neurosci; 2002; 19(1-2):31-5. PubMed ID: 12212790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies.
    Evin G; Sernee MF; Masters CL
    CNS Drugs; 2006; 20(5):351-72. PubMed ID: 16696577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes.
    Vetrivel KS; Cheng H; Lin W; Sakurai T; Li T; Nukina N; Wong PC; Xu H; Thinakaran G
    J Biol Chem; 2004 Oct; 279(43):44945-54. PubMed ID: 15322084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains.
    Wahrle S; Das P; Nyborg AC; McLendon C; Shoji M; Kawarabayashi T; Younkin LH; Younkin SG; Golde TE
    Neurobiol Dis; 2002 Feb; 9(1):11-23. PubMed ID: 11848681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts.
    Riddell DR; Christie G; Hussain I; Dingwall C
    Curr Biol; 2001 Aug; 11(16):1288-93. PubMed ID: 11525745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts.
    Vetrivel KS; Meckler X; Chen Y; Nguyen PD; Seidah NG; Vassar R; Wong PC; Fukata M; Kounnas MZ; Thinakaran G
    J Biol Chem; 2009 Feb; 284(6):3793-803. PubMed ID: 19074428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of disease: new therapeutic strategies for Alzheimer's disease--targeting APP processing in lipid rafts.
    Cheng H; Vetrivel KS; Gong P; Meckler X; Parent A; Thinakaran G
    Nat Clin Pract Neurol; 2007 Jul; 3(7):374-82. PubMed ID: 17611486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein.
    Hooper NM
    Biochem Soc Trans; 2005 Apr; 33(Pt 2):335-8. PubMed ID: 15787600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence.
    Kimura A; Hata S; Suzuki T
    J Biol Chem; 2016 Nov; 291(46):24041-24053. PubMed ID: 27687728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.
    Harris B; Pereira I; Parkin E
    Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A partial failure of membrane protein turnover may cause Alzheimer's disease: a new hypothesis.
    Sambamurti K; Suram A; Venugopal C; Prakasam A; Zhou Y; Lahiri DK; Greig NH
    Curr Alzheimer Res; 2006 Feb; 3(1):81-90. PubMed ID: 16472208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
    Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
    J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.
    Vassar R; Bennett BD; Babu-Khan S; Kahn S; Mendiaz EA; Denis P; Teplow DB; Ross S; Amarante P; Loeloff R; Luo Y; Fisher S; Fuller J; Edenson S; Lile J; Jarosinski MA; Biere AL; Curran E; Burgess T; Louis JC; Collins F; Treanor J; Rogers G; Citron M
    Science; 1999 Oct; 286(5440):735-41. PubMed ID: 10531052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.